HIMS - Hims & Hers Health, Inc.

15.82
-0.660   -4.172%

Share volume: 27,310,750
Last Updated: 03-03-2026
Healthcare/Services – Health: -0.06%

PREVIOUS CLOSE
CHG
CHG%
$16.48
-0.66
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 49%
Dept financing 30%
Liquidity 39%
Performance 34%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
8.95%
1 Month
-35.16%
3 Months
-60.47%
6 Months
-67.12%
1 Year
-60.93%
2 Year
7.62%
Key data
Stock price
$15.82
P/E Ratio 
57.58
DAY RANGE
$15.27 - $16.91
EPS 
$0.50
52 WEEK RANGE
$13.74 - $70.43
52 WEEK CHANGE
-$61.31
MARKET CAP 
7.392 B
YIELD 
N/A
SHARES OUTSTANDING 
227.939 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-04-2025
BETA 
4.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$36,955,638
AVERAGE 30 VOLUME 
$39,446,481
Company detail
CEO: Andrew Dudum
Region: US
Website: forhims.com
Employees: 650
IPO year: 2019
Issue type: Common Stock
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category. In addition, it offers medical consultation services and health and wellness products through wholesale partners.

Recent news